Work

Evaluation of combretastatin A-4 prodrug in a non-Hodgkin’s lymphoma xenograft model: preclinical efficacy

Year: 2001

Type: article

Source: Anti-Cancer Drugs

DOI: 10.1097/00001813-200101000-00008

Authors: Sanaa M Nabha, Ramzi M Mohammad, Nathan R Wall, Julie A Dutcher, Bashar M Salkini, George R Pettit, Ayad M Al-Katib

Institutions: Wayne State University, Arizona State University

Language: English

Topic: Angiogenesis and VEGF in Cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: OUTSTANDING INVESTIGATOR, G5932337109, G678883038, POTENTIATION OF 2CDA ACTIVITY IN CLL BY BRYOSTATIN 1, CANCER CENTER SUPPORT GRANT

OpenAlex ID: W1968677495

FWCI: 0.286

Cites: 24

Cited by: 26

Related to: 10